TEMESTA Safety Questions, TEMESTA Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about TEMESTA. Our extensive database of TEMESTA adverse events and TEMESTA warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about TEMESTA
TEMESTA Safety Reports
Total TEMESTA reports: 36.TEMESTA FDA safety alerts: No.
Reported deaths: 7 Reported hospitalizations: 26.
Take TEMESTA Side Effects Survey or Share Your TEMESTA Story. Read More Here.
Health Professional from SWITZERLAND reported TEMESTA problem on Jan 08, 2007. Male patient, 41 years of age, was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: back pain, bone pain, chest discomfort, chest pain, nightmare, sensation of pressure, sensory disturbance. TEMESTA dosage: unknown. During the same period patient was treated with NEUPOGEN, NAVOBAN, PRIMPERAN, FOTECORTIN, NEXIUM, ZYLORIC. Patient recovered.
TEMESTA problem was reported by a Consumer or non-health professional from FRANCE on Jan 19, 2007. Male patient, 84 years of age, was diagnosed with anxiety, hypertension, arteritis, atrial fibrillation and was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: fall, hyponatraemia, orthostatic hypotension. TEMESTA dosage: 1 MG, QD. During the same period patient was treated with LASIX, XATRAL, CORDARONE, CREON, IMODIUM, MINISINTROM, ALDALIX, NISIS. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from SWITZERLAND reported TEMESTA problem on Jan 12, 2007. Female patient was diagnosed with anxiety disorder, pain and was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: apnoea, confusional state, hallucination, visual, myoclonus. TEMESTA dosage: unknown. During the same period patient was treated with BUPRENORPHINE, MORPHINE, TRAMADOL, NEURONTIN, LIORESAL, DAFALGAN. Patient was hospitalized. Patient recovered.
TEMESTA problem was reported by a Health Professional from FRANCE on Jan 23, 2007. Male patient, 61 years of age, was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: bacterial infection, cardiac arrest, coma, completed suicide, haemorrhagic anaemia, hypoxia, intentional overdose, livedo reticularis, lung consolidation. TEMESTA dosage: unknown. During the same period patient was treated with EFFEXOR, BROMAZEPAM, PAROXETINE, MITOTANE, DAFALGAN, HEXAQUINE, HYDROCORTISONE, FLUDROCORTISONE. Patient was hospitalized. Patient died on 11/20/2006.
Consumer or non-health professional from SWITZERLAND reported TEMESTA problem on Jan 25, 2007. Male patient, 41 years of age, was diagnosed with aggression and was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: aggression, alanine aminotransferase decreased, amnesia, aspartate aminotransferase decreased, blood alkaline phosphatase increased, confusional state, disorientation, gait disturbance, gamma-glutamyltransferase increased. TEMESTA dosage: 7.5 MG Q DAY UNK. During the same period patient was treated with PANTOZOL, AKINETON, CLOPIXOL, LITHIUM CARBONATE, LITHIUM CARBONATE, SEROPRAM, TEGRETOL. Patient was hospitalized. Patient recovered.
TEMESTA problem was reported by a Health Professional from SWITZERLAND on Feb 28, 2007. Female patient was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: foetal distress syndrome, foetal growth retardation, oligohydramnios. TEMESTA dosage: unknown. During the same period patient was treated with FLUCTINE, ZYRTEC. Patient died on 07/07/2005.
Consumer or non-health professional from SWITZERLAND reported TEMESTA problem on Feb 28, 2007. Female patient, 30 years of age, was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: dehydration, dizziness, hypotension, oxygen saturation decreased, sedation. TEMESTA dosage: 2.5 MG Q;DAY;PO. During the same period patient was treated with ZYPREXA. Patient was hospitalized. Patient recovered.
TEMESTA problem was reported by a Health Professional from SWITZERLAND on Feb 28, 2007. Female patient, 38 years of age, was diagnosed with conduct disorder, depression, urticaria and was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: foetal distress syndrome, foetal growth retardation, oligohydramnios, pregnancy, premature baby. TEMESTA dosage: unknown. During the same period patient was treated with FLUCTINE, ZYRTEC. Patient recovered.
Health Professional from SWITZERLAND reported TEMESTA problem on Mar 02, 2007. Male patient, 42 years of age, was diagnosed with epilepsy and was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: hallucination, paranoia. TEMESTA dosage: 5 MG Q DAY PO. During the same period patient was treated with KEPPRA, LISINOPRIL, BELOC, DORMICUM, PLAVIX, PRAZINE. Patient recovered.
TEMESTA problem was reported by a Consumer or non-health professional from FRANCE on Mar 07, 2007. Female patient, 65 years of age, was diagnosed with depression and was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, histiocytosis haematophagic, leukopenia, neutropenia, white blood cell count increased. TEMESTA dosage: 1 MG Q DAY PO. During the same period patient was treated with EFFEXOR, ACUPAN, NEXIUM, LOXEN, PERFALGAN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from SWITZERLAND reported TEMESTA problem on Mar 16, 2007. Female patient, 30 years of age, was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: hypotension, oxygen saturation decreased, sedation. TEMESTA dosage: 2.5 MG Q DAY PO. During the same period patient was treated with ZYPREXA. Patient was hospitalized. Patient recovered.
TEMESTA problem was reported by a Health Professional from SWITZERLAND on Mar 16, 2007. Female patient, 81 years of age, weighting 101.6 lb, was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, agitation, dehydration, delirium, depressed level of consciousness, fluid intake reduced, hallucination, visual, renal failure, restlessness. TEMESTA dosage: 2.5 MG Q DAY PO. During the same period patient was treated with ZYPREXA, ASPIRIN. Patient was hospitalized. Patient recovered.
Physician from FINLAND reported TEMESTA problem on Apr 10, 2007. Male patient, 30 years of age, was diagnosed with schizophrenia and was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, neutropenia, respiratory tract infection. TEMESTA dosage: 2 MG/DAY. During the same period patient was treated with NEUROBIONTE, KALCIPOS, ZOPINOX, ZYPREXA, KLAMATH WEED PREPARATION, CLOZAPINE. Patient was hospitalized. Patient recovered.
TEMESTA problem was reported by a Consumer or non-health professional from FRANCE on Mar 28, 2007. Male patient, 66 years of age, was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, coordination abnormal, fall, parkinsonism. TEMESTA dosage: 1 MG TID PO. During the same period patient was treated with AVLOCARDYL, FLUOXETINE, STILNOX, TERCIAN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported TEMESTA problem on Apr 24, 2007. Male patient, 84 years of age, was diagnosed with anxiety, hypertension, arteritis, atrial fibrillation and was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, fall, hyponatraemia, orthostatic hypotension. TEMESTA dosage: 1 MG, QD. During the same period patient was treated with LASIX, XATRAL, CORDARONE, CREON, IMODIUM, MINISINTROM, ALDALIX, NISIS. Patient was hospitalized. Patient recovered.
TEMESTA problem was reported by a Physician from SWITZERLAND on Apr 13, 2007. Female patient was diagnosed with anxiety, suicidal ideation and was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: acute coronary syndrome, akathisia, balance disorder, cardiac arrest, cardiovascular disorder, cerebral ischaemia, cerebrovascular spasm, choking, cogwheel rigidity. TEMESTA dosage: 7.5 MG QD ORAL. During the same period patient was treated with RISPERDAL, TOLVON. Patient was hospitalized. Patient died on 03/21/2007.
Consumer or non-health professional from AUSTRIA reported TEMESTA problem on Apr 27, 2007. Female patient was diagnosed with agitation, depression, insomnia and was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: circulatory collapse, fall, injury, joint dislocation, tendon rupture. TEMESTA dosage: 1.75 MG QD. Patient was hospitalized. Patient recovered.
TEMESTA problem was reported by a Consumer or non-health professional from SWITZERLAND on May 21, 2007. Male patient was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: back pain, bone pain, chest discomfort, chest pain, nightmare, sensation of pressure, sensory disturbance. TEMESTA dosage: unknown. During the same period patient was treated with NEUPOGEN, NAVOBAN, PRIMPERAN, FORTECORTIN, NEXIUM, ALLOPURINOL. Patient recovered.
Physician from SWITZERLAND reported TEMESTA problem on May 21, 2007. Female patient, weighting 108.0 lb, was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: concussion, crush injury, fall, orthostatic hypotension, skin laceration. TEMESTA dosage: (2 MG QD ORAL). During the same period patient was treated with EFFEXOR, REMERON, SEROQUEL. Patient was hospitalized. Patient recovered.
TEMESTA problem was reported by a Physician from SWITZERLAND on May 23, 2007. Female patient was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: fall, foot fracture, gait disturbance, hypotension, sedation, vertigo. TEMESTA dosage: (4 MG QD ORAL). During the same period patient was treated with ASPIRIN, BELOC ZOK, ORFIRIL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from SWITZERLAND reported TEMESTA problem on May 29, 2007. Female patient, weighting 101.6 lb, was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, agitation, altered state of consciousness, blood glucose decreased, dehydration, delirium, fluid intake reduced, hallucination, visual, renal failure. TEMESTA dosage: 2.5 MG QD ORAL. During the same period patient was treated with ZYPREXA, ASPIRIN. Patient was hospitalized. Patient recovered.
TEMESTA problem was reported by a Health Professional from SWITZERLAND on May 29, 2007. Female patient was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: dizziness, hypotension, oxygen saturation decreased, sedation, somnolence. TEMESTA dosage: (2.5 MG QD ORAL), (2 MG QD ORAL). During the same period patient was treated with ZYPREXA. Patient was hospitalized. Patient recovered.
Health Professional from FRANCE reported TEMESTA problem on July 04, 2006. Male patient, 84 years of age, was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: international normalised ratio increased, urinary bladder haemorrhage, urinary retention. TEMESTA dosage: 1 MG Q DAY PO. During the same period patient was treated with EUPANTOL, HEMIGOXINE NATIVELLE, GLUCOR, NOVONORM, NORSET. Patient was hospitalized. Patient recovered.
TEMESTA problem was reported by a Physician from FRANCE on July 24, 2006. Male patient was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: disease progression. TEMESTA dosage: unknown. During the same period patient was treated with THERALENE, OMEPRAZOLE, KABIVEN, STILNOX, FUNGIZONE, BICARBONATE, ZOPHREN. Patient was hospitalized. Patient recovered.
Physician from SWITZERLAND reported TEMESTA problem on July 07, 2006. Male patient, 43 years of age, was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: blood pressure diastolic increased, blood pressure systolic increased, gastrooesophageal reflux disease, hiccups, tachycardia, vomiting. TEMESTA dosage: 3.5 MG QD PO. During the same period patient was treated with STILNOX, NOVALGIN, METHADONE, PROMAZINE HYDROCHLORIDE, METAMIZOLE. Patient recovered.
TEMESTA problem was reported by a Consumer or non-health professional from DENMARK on July 19, 2006. Female patient, 73 years of age, was diagnosed with anxiety, dyspnoea, panic attack and was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: respiratory arrest. TEMESTA dosage: 1 MG QD; PO. During the same period patient was treated with MORPHINE. Patient was hospitalized. Patient died on 07/09/2006.
Physician from SWITZERLAND reported TEMESTA problem on July 19, 2006. Male patient, 52 years of age, was diagnosed with anxiety, depression and was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: gastrointestinal hypermotility, serotonin syndrome, sleep disorder. TEMESTA dosage: 2 MG Q DAY PO. During the same period patient was treated with SERESTA. Patient was hospitalized. Patient recovered.
TEMESTA problem was reported by a Consumer or non-health professional from FRANCE on July 21, 2006. Female patient was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: abortion induced, amniotic fluid volume decreased, congenital cystic kidney disease, potter's syndrome, pulmonary hypoplasia. TEMESTA dosage: unknown. During the same period patient was treated with ADEPAL, ALPRAZOLAM, CATAPRES, FOSINOPRIL, HYDROCHLOROTHIAZIDE, LEVOTHYROXINE. Patient died on 04/14/2003.
Consumer or non-health professional from FRANCE reported TEMESTA problem on July 21, 2006. Female patient, 39 years of age, was diagnosed with anxiety, contraception, hypertension, hypothyroidism and was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: abortion induced, foetal disorder, oligohydramnios, pregnancy on oral contraceptive, renal hypertrophy, unintended pregnancy. TEMESTA dosage: unknown. During the same period patient was treated with ADEPAL, ALPRAZOLAM, CATAPRESAN, FOSINOPRIL, HYDROCHLOROTHIAZIDE, LEVOTHYROXINE. Patient recovered.
TEMESTA problem was reported by a Health Professional from SWITZERLAND on Aug 04, 2006. Male patient, 62 years of age, was diagnosed with anxiety disorder, parkinson's disease, urinary incontinence and was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: anxiety, chills, condition aggravated, hallucination, visual, nocturia. TEMESTA dosage: unknown. During the same period patient was treated with CHLORALDURAT, COMTAN, DETRUSITOL, MADOPAR DR, MADOPAR DR, MADOPAR LIQ, REQUIP. Patient was hospitalized. Patient recovered.
Health Professional from SWITZERLAND reported TEMESTA problem on Aug 04, 2006. Female patient, 49 years of age, was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: somnolence, sopor, suicide attempt, urinary tract infection. TEMESTA dosage: 50 MG ONCE PO. During the same period patient was treated with DEPAKENE. Patient was hospitalized. Patient recovered.
TEMESTA problem was reported by a Consumer or non-health professional from SWITZERLAND on Dec 11, 2006. Female patient, 40 years of age, was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: abortion induced, pregnancy. TEMESTA dosage: unknown. Patient died.
Health Professional from FRANCE reported TEMESTA problem on June 25, 2007. Male patient, 66 years of age, was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: akinesia, blood glucose increased, coordination abnormal, fall, hypertonia, parkinsonism. TEMESTA dosage: ( 1 MG TID ORAL). During the same period patient was treated with AVLOCARDYL, FLUOXETINE, STILNOX, TERCIAN. Patient was hospitalized. Patient recovered.
TEMESTA problem was reported by a Consumer or non-health professional from SWITZERLAND on June 27, 2007. Female patient, 34 years of age, was diagnosed with anxiety and was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: asthmatic crisis. TEMESTA dosage: (3.5 MG QD ORAL), (1 DF QD). During the same period patient was treated with AXOTIDE, TOPAMAX, CETIRIZINE, FLUOXETINE, SEREVENT. Patient recovered.
Health Professional from SWITZERLAND reported TEMESTA problem on June 29, 2007. Male patient was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: altered state of consciousness, cyanosis, hyperglycaemia, ketoacidosis, pneumonia, renal failure acute, respiratory depression, rhabdomyolysis. TEMESTA dosage: 2.5 MG TID ORAL. During the same period patient was treated with DORMICUM, STILNOX, TRANXILIUM, ATORVASTATIN CALCIUM, ACETAMINOPHEN, NORVASC, BELOC, PLAVIX. Patient was hospitalized. Patient died on 05/06/2007.
TEMESTA problem was reported by a Health Professional from SWITZERLAND on July 13, 2007. Male patient was treated with TEMESTA. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, altered state of consciousness, aspartate aminotransferase increased, cyanosis, diabetic ketoacidosis, hyperglycaemia, pneumonia, renal failure acute, respiratory depression. TEMESTA dosage: 2.5 MG TID, ORAL. During the same period patient was treated with DORMICUM, STILNOX, TRANXILIUM, SORTIS, ACETAMINOPHEN, NORVASC, BELOC, TOREM. Patient was hospitalized. Patient died on 05/06/2007.
This
drug has an active FDA Safety Alert